Effect of Prophylactic Antifungal Protocols on the Prognosis of Liver Transplantation: A Propensity Score Matching and Multistate Model Approach

Table 4

Results of multivariable transition-specific Cox models.

Variable	Category	HR (95% CI)	value
Transition: transplant to fungal infection
Treatment	No prophylaxis	1
	Prophylaxis	0.57 (0.34–0.96)	0.033
Ascites	Mild/moderate	1
	Massive	1.65 (0.98–2.76)	0.058
Propensity score		0.15 (0.01–1.76)	0.132
Transition: transplant to death
Ascites	Mild/moderate	1
	Massive	1.55 (1.02–2.36)	0.042
Living donor; (within 1.5 years)	No	1
	Yes	0.41 (0.26–0.66)	<0.001
Living donor; (after 1.5 years)	No	1
	Yes	1.08 (0.45–2.62)	0.861
Transition: fungal infection to death
Age (years)	≤50	1
	>50, ≤60	2.55 (1.10–5.93)	0.029
	>60	1.80 (0.67–4.83)	0.240
Ascites	Mild/moderate	1
	Massive	2.19 (1.06–4.52)	0.035
Living donor	No	1
	Yes	0.57 (0.28–1.14)	0.113

HR: hazard ratio and CI: confidence interval. .